Corindus Announces New CEO to Lead Vascular Robotic Technology Company

(BUSINESS WIRE)--Corindus, Inc. announced the appointment of David M. Handler as President and CEO. He will drive the continued development and subsequent commercialization of the company’s innovative vascular robotic system. Mr. Handler, who started in his position on Oct 1st, replaced Frank Martin.

“I am excited to welcome David to Corindus, his leadership capability and experience in developing and commercializing medical technology is ideally suited to our company. We are happy to have him on board at this important time for our company as we move to the next stage of our strategy.” says Hillel Bachrach, Chairman of the Board. “We are grateful for Frank Martin’s results in building the business the past two years.” Mr. Martin remains on the Board of Directors.

Peter Fitzgerald, MD, Ph D, Corindus’ Medical Director said “I am looking forward to Mr. Handler’s leadership in continuing to implement and expand the clinical vision for robotic technology to improve outcomes in vascular interventional medicine.”

Corindus develops vascular robotic systems that place discrete technology in the hands of interventionalists, uniting the physician’s distinctive skill set with robotic precision. The open architecture robotic arm manipulates standard cath lab devices with physician guidance, allowing accurate placement of guide wires and balloon/stent delivery systems from a safe, comfortable remote workstation.

Before joining Corindus, Mr. Handler spent more than 20 years at General Electric. In 2001, Mr. Handler was selected to lead marketing for GE Healthcare’s newly-formed Interventional Cardiology business unit, including the cath lab imaging, monitoring and IT businesses. Most recently he served as General Manager for the Global MRI marketing department. Prior to that, he held a variety of sales, marketing and product management leadership positions at GE. He holds a BA in economics from Union College, Schenectady NY and has extensive management training from GE’s Jack Welch Leadership Development Center in Crotonville, NY.

About Corindus

Corindus designs, manufactures and commercializes patented vascular robotic systems designed specifically for percutaneous applications. The company’s system enables the interventional physician to perform catheterization procedures from a remote location, beyond the radiation zone. Compatible with state-of-the-art cardiology products and cath lab imaging technologies, the Corindus technology mechanically maneuvers devices through patients’ arteries as specified by the physician at a remote workstation. The proprietary technology utilizes physician fluoroscopic control similar to routine practice to allow maneuvering and torquing of cath lab devices. Initial clinical trials have demonstrated safety and efficacy. The system will easily integrate into an existing cath lab room with simple installation and little downtime. This product is not currently available for sale.

Back to news